NCT06642311 Bladder Distension for Pain Relief in Patients With Excessive Anteflexion of Uterus Undergoing Office Hysteroscopy
| NCT ID | NCT06642311 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Hysteroscopy |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2024-10-30 |
| Primary Completion | 2025-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2024-10-30 with a primary completion date of 2025-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is conducted to assess whether the passive uterine straightening of the uterus by means of bladder filling is associated with less pain experienced by patients with excessive anteflexion of the uterus during office hysteroscopy.
Eligibility Criteria
Inclusion Criteria: * Patients with excessive anteflexion of the uterus Exclusion Criteria: * Cervical pathology * Previous cervical surgery * Severe vaginal bleeding
Contact & Investigator
Usama M Fouda, Prof,
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT06642311 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 60 Years, studying Hysteroscopy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06642311 currently recruiting?
Yes, NCT06642311 is actively recruiting participants. Contact the research team at umfrfouda@kasralainy.edu.eg for enrollment information.
Where is the NCT06642311 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06642311 clinical trial?
NCT06642311 is sponsored by Cairo University. The principal investigator is Usama M Fouda, Prof, at Cairo University. The trial plans to enroll 48 participants.